WormBase Tree Display for Transgene: WBTransgene00033745
expand all nodes | collapse all nodes | view schema
WBTransgene00033745 | Public_name | xchIs015 | ||||||
---|---|---|---|---|---|---|---|---|
Summary | [pLSD134 Phsp-16.2::ssSel1::FLAG::superfolderGFP::spacer::humanAmyloidBeta1-42::let-858-3UTR; pRF4 rol-6(su1006)]. | |||||||
Construction | Construct | WBCnstr00004720 | ||||||
Construction_summary | transgene that drives the expression via a heat shock promoter to induce and secret sfGFP::A1-42 (Jongsma et al., 2023). | |||||||
Genetic_information | Integrated | |||||||
Phenotype | WBPhenotype:0001405 | Curator_confirmed | WBPerson712 | |||||
Remark | heat shock induced sfGFP::A1-42 expression and secretion with 3 hours of heat shock (Figure 1A). "we assessed sfGFP::A1-42 aggregation levels after 48 hours post-induction. Fluorescent images of the control group revealed extensive induction and aggregation of A in the cuticle, coelomocytes, and the tail (Figure 1E)."; "Screening results of various drugs indicated optimal dosages and combinations, with quercetin 350 M and rifampicin 75 M producing the largest visible reduction in amyloid burden. Higher dosages of drugs resulted in extensive death of C. elegans with rifampicin 175-200 M, quercetin 450-500 M, and alpha-ketoglutarate (aKG) 12-16 mM (Figure 1C, Screen 1)." | Curator_confirmed | WBPerson712 | |||||
Affected_by | Molecule | WBMol:00001874 | Curator_confirmed | WBPerson712 | ||||
WBMol:00003989 | Curator_confirmed | WBPerson712 | ||||||
Temperature_sensitive | Heat_sensitive | Curator_confirmed | WBPerson712 | |||||
Reference | WBPaper00066270 | |||||||
Species | Caenorhabditis elegans |